Pamela Peters, from Biotechnology: A Guide To Genetic Engineering. Wm. C. Brown Publishers, Inc., 1993.

Biotechnology in one form or another has flourished since prehistoric times. When the first human beings realized that they could plant their own crops and breed their own animals, they learned to use biotechnology. The discovery that fruit juices fermented into wine, or that milk could be converted into cheese or yogurt, or that beer could be made by fermenting solutions of malt and hops began the study of biotechnology. When the first bakers found that they could make a soft, spongy bread rather than a firm, thin cracker, they were acting as fledgling biotechnologists. The first animal breeders, realizing that different physical traits could be either magnified or lost by mating appropriate pairs of animals, engaged in the manipulations of biotechnology.

What then is biotechnology? The term brings to mind many different things. Some think of developing new types of animals. Others dream of almost unlimited sources of human therapeutic drugs. Still others envision the possibility of growing crops that are more nutritious and naturally pest-resistant to feed a rapidly growing world population. This question elicits almost as many first-thought responses as there are people to whom the question can be posed.

In its purest form, the term "biotechnology" refers to the use of living organisms or their products to modify human health and the human environment. Prehistoric biotechnologists did this as they used yeast cells to raise bread dough and to ferment alcoholic beverages, and bacterial cells to make cheeses and yogurts and as they bred their strong, productive animals to make even stronger and more productive offspring.

Throughout human history, we have learned a great deal about the different organisms that our ancestors used so effectively. The marked increase in our understanding of these organisms and their cell products gains us the ability to control the many functions of various cells and organisms. Using the techniques of gene splicing and recombinant DNA technology, we can now actually combine the genetic elements of two or more living cells. Functioning lengths of DNA can be taken from one organism and placed into the cells of another organism. As a result, for example, we can cause bacterial cells to produce human molecules. Cows can produce more milk for the same amount of feed. And we can synthesize therapeutic molecules that have never before existed.

Go to next story: Where Did Biotechnology Begin?

Return to About Biotech directory

Read more here:
What is Biotechnology ? - Access Excellence

A disruptive technology that saves lives and improves patient care Main menu Marx Biotechnology is developing a proprietary first-in-class molecular diagnostic kit for the early detection of Graft versus Host Disease (GVHD). GVHD is a life threatening complication of allogeneic (non-self) stem cell transplantation such as bone marrow, peripheral blood or cord blood transplantation

and solid organ transplantations. The cells from the donor react

adversely to the cells in the patient. GVHD affects approximately 50% of all such transplant patients, frequently resulting in death. https://www.youtube.com/watch?v=c_8PcfZSkrI Marx Bios approach has 5 clear advantages:

Incorporated in Jerusalem in January 2011, the Marx Bio team has completed proof of concept in animal studies, has published in a peer reviewed journal, and has filed three patents. It is commencing a Phase 1 clinical trial in humans in Tel Aviv.

Marx Bio has a clear work schedule to deliver a validated and cleared product, ready for market entry within 36 to 48 months. The company is looking for strategic partners to join in that journey.

See the article here:
Marx Biotechnology A disruptive technology that saves ...

I like the fact that I get notified when someone wants my resume, and that you only give my personal information to real employers with real jobs.

Just a short note in praise of your service which has allowed our start-up company to surface and hire almost every position we reviewed from Medzilla.

One of my former employers saw my CV on Medzilla and contacted me. I am now re-employed by that employer.

I am seriously impressed with the level of involvement you have in this website and my job search! Thank you for your attention and efforts.

We did hire from your website, which compared to a recruiter fee, saved a tremendous amount of money! Thanks for your help.

I've had 3 calls w/in a 48 hour period of posting my resume. I appreciate the thorough nature of MEDZILLA's follow up with emails each time my resume has been sent and the respect for privacy your company has shown.

We eventually hired a young man that we found through MedZilla and he has been a real asset to our corporation. My only regret is that we aren't a larger company that could use your services more often!

The rest is here:
Medzilla;Biotech Jobs, Pharmaceutical Jobs, Pharmaceutical ...

"Bioscience" redirects here. For the scientific journal, see BioScience. For life sciences generally, see life science.

Biotechnology is the use of living systems and organisms to develop or make products, or "any technological application that uses biological systems, living organisms or derivatives thereof, to make or modify products or processes for specific use" (UN Convention on Biological Diversity, Art. 2).[1] Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, etc.

For thousands of years, humankind has used biotechnology in agriculture, food production, and medicine.[2] The term is largely believed to have been coined in 1919 by Hungarian engineer Kroly Ereky. In the late 20th and early 21st century, biotechnology has expanded to include new and diverse sciences such as genomics, recombinant gene techniques, applied immunology, and development of pharmaceutical therapies and diagnostic tests.[2]

The wide concept of "biotech" or "biotechnology" encompasses a wide range of procedures for modifying living organisms according to human purposes, going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization. Modern usage also includes genetic engineering as well as cell and tissue culture technologies. The American Chemical Society defines biotechnology as the application of biological organisms, systems, or processes by various industries to learning about the science of life and the improvement of the value of materials and organisms such as pharmaceuticals, crops, and livestock.[3] As per European Federation of Biotechnology, Biotechnology is the integration of natural science and organisms, cells, parts thereof, and molecular analogues for products and services.[4] Biotechnology also writes on the pure biological sciences (animal cell culture, biochemistry, cell biology, embryology, genetics, microbiology, and molecular biology). In many instances, it is also dependent on knowledge and methods from outside the sphere of biology including:

Conversely, modern biological sciences (including even concepts such as molecular ecology) are intimately entwined and heavily dependent on the methods developed through biotechnology and what is commonly thought of as the life sciences industry. Biotechnology is the research and development in the laboratory using bioinformatics for exploration, extraction, exploitation and production from any living organisms and any source of biomass by means of biochemical engineering where high value-added products could be planned (reproduced by biosynthesis, for example), forecasted, formulated, developed, manufactured and marketed for the purpose of sustainable operations (for the return from bottomless initial investment on R & D) and gaining durable patents rights (for exclusives rights for sales, and prior to this to receive national and international approval from the results on animal experiment and human experiment, especially on the pharmaceutical branch of biotechnology to prevent any undetected side-effects or safety concerns by using the products).[5][6][7]

By contrast, bioengineering is generally thought of as a related field that more heavily emphasizes higher systems approaches (not necessarily the altering or using of biological materials directly) for interfacing with and utilizing living things. Bioengineering is the application of the principles of engineering and natural sciences to tissues, cells and molecules. This can be considered as the use of knowledge from working with and manipulating biology to achieve a result that can improve functions in plants and animals.[8] Relatedly, biomedical engineering is an overlapping field that often draws upon and applies biotechnology (by various definitions), especially in certain sub-fields of biomedical and/or chemical engineering such as tissue engineering, biopharmaceutical engineering, and genetic engineering.

Although not normally what first comes to mind, many forms of human-derived agriculture clearly fit the broad definition of "'utilizing a biotechnological system to make products". Indeed, the cultivation of plants may be viewed as the earliest biotechnological enterprise.

Agriculture has been theorized to have become the dominant way of producing food since the Neolithic Revolution. Through early biotechnology, the earliest farmers selected and bred the best suited crops, having the highest yields, to produce enough food to support a growing population. As crops and fields became increasingly large and difficult to maintain, it was discovered that specific organisms and their by-products could effectively fertilize, restore nitrogen, and control pests. Throughout the history of agriculture, farmers have inadvertently altered the genetics of their crops through introducing them to new environments and breeding them with other plants one of the first forms of biotechnology.

These processes also were included in early fermentation of beer.[9] These processes were introduced in early Mesopotamia, Egypt, China and India, and still use the same basic biological methods. In brewing, malted grains (containing enzymes) convert starch from grains into sugar and then adding specific yeasts to produce beer. In this process, carbohydrates in the grains were broken down into alcohols such as ethanol. Later other cultures produced the process of lactic acid fermentation which allowed the fermentation and preservation of other forms of food, such as soy sauce. Fermentation was also used in this time period to produce leavened bread. Although the process of fermentation was not fully understood until Louis Pasteur's work in 1857, it is still the first use of biotechnology to convert a food source into another form.

Before the time of Charles Darwin's work and life, animal and plant scientists had already used selective breeding. Darwin added to that body of work with his scientific observations about the ability of science to change species. These accounts contributed to Darwin's theory of natural selection.[10]

Read more from the original source:
Biotechnology - Wikipedia, the free encyclopedia

Biotechnology can help in controlling oil spillage
A video documentary by #AIT Nigeria showing how #biotechnology can help control #pollution in the oil spillage areas through #Bioremediation.

By: OFAB Nigeria Abuja

Read more from the original source:
Biotechnology can help in controlling oil spillage - Video

3. Platz Houskapreis 2015: BOKU Wien, Vienna Institute of Biotechnology (VIBT)
(c) 2015 Strukt http://www.strukt.com Eine Produktion im Auftrag der B C Privatstiftung ====================================== Projekt: Herstellung von humanen Zellkulturen als Zellfabrik, Produkt.

By: Houskapreis - der Forschungspreis der B C Privatstiftung

Go here to read the rest:
3. Platz Houskapreis 2015: BOKU Wien, Vienna Institute of Biotechnology (VIBT) - Video

Dr. Scott Shaffer presents: "A New Form of Biotechnology: Novel Data Logging Devices..."
Moss Landing Marine Labs Seminar Series April 9, 2015 Presenter: Dr. Scott Shaffer Institution: San Jose State University Title: "A New Form of Biotechnology: Novel data logging devices reveal...

By: Moss Landing Marine Labs

Follow this link:
Dr. Scott Shaffer presents: "A New Form of Biotechnology: Novel Data Logging Devices..." - Video

A breakthrough has been achieved in the stream of medical science. An alternative to the metallic stent has been found and is called biodegradable or bio-absorbable stents.

Difference between the two

Metallic stents which are in use for a long time now, had some disadvantages. These stents helps to keep the blocked arteries open to enable the flow of oxygen and blood, but also causes retenosis, that is, it scars up vessel tissue causing the arteries to clog again. Even though drug infused metallic stents have also been used as an alternative, it still does not lower the risks of other complications.

Biodegradable stents, on the other hand causes no such complications. It opens up the blocked arteries and dissolves itself after fulfilling its task, thus, minimizing the occurrence of any complication. It is made up of poly-l-lactide, a naturally dissolving material. It is said to dissolve in a time span of 18 months to three years. Another advantage of this stent is that it does not prevent the detection of other blockages as opposed to the metallic stents which would refract the rays of the scan, making it hard for detection.

Benefits of not having a permanent stent

One of the greatest benefits of not having a permanent stent is that it allows the lumen to expand. When a permanent metallic stent is used it does not allow the lumen to grow, thus hindering remodeling even though it allows the vessel around the stent to develop.

Another benefit is they do not produce any kind of inflammatory reactions as opposed to metallic stents.

How does a biodegradable stent work?

Arteries start getting clogged up due to the accumulation of fatty matter like chlorestol on the inner wall of the arteries that are responsible for providing blood to the heart. As it advances, it reduces the width of the lumen in return diminishing the amount of blood flowing into the heart. This is when a person undergoes a chest pain known as angina.

This disease can be arrested at the initial stage with the help of medication. But a person suffers a heart attack when the precautions are not taken, or when the artery is fully obstructed. That is when the surgical procedure of angioplasty is done. In angioplasty, a balloon is introduced into the artery through a guide wire and is inflated where the blockage is located. After this the stent is introduced so that it keeps the artery open.

The biodegradable stent releases a drug called everolimus which prevents irregular tissue growth.

Researches and studies that classify biodegradable as safe

Kunhiko Kosuga, who has a MD, PhD and is also the director of cardiology at Shiga Medical Center for Adults in Moriyana City, Japan, did a research on these new stents. He and his fellow researchers studied 44 men and 6 women who had undergone angioplasty and had used biodegradable stents to open up the affected arteries. They looked for various complications like clots, deaths, and other causes. The result is as follows:

? for the deaths associated with heart diseases, the survival rate was 98%.

? for death from all causes, the survival rate was 87%.

? there was no main cardiac problems in half the patients.

? Only four patients suffered heart attacks.

? The blood vessel involved had re-narrowed in 16% of the patients, in one year after undergoing the procedure.

? there were two clots that were found within the stent. One was due to the drug-infused stent close to the biodegradable one.

Countries who welcomed biodegradable stents

Nine European countries, Middle East, parts of Latin America and parts of Asia like India, Hong Kong, Philippines and Vietnam are already using these stents. In Europe, Asia-Pacific, Canada and Latin America, over 600 patients have taken part in the trial which aspires to have 1000 patients from over 100 centres present in these counties. Even Singapore has approved of these stents from 20th December, 2012.

However, doctors are still awaiting results for the long term effects on the patients

Even though the cost for manufacturing these stents is very expensive, doctors worldwide are optimistic that they will replace metallic stents eventually.

About The Author: Alia is a writer/blogger by profession. She loves writing, travelling and reading books. She contributes to Hydroxycut

Source:
http://www.biotechblog.org/entry/biodegradable-heart-stents-safe/

Home pregnancy tests have been practiced for long by women and is quite trusted way of confirming your doubts when it comes to conceiving. Here are certain signs that can tell you that you are probably pregnant.

If you have missed your period or you are having an abnormal or unusual period may be you are pregnant. If you have got frequent urinating tendencies or you throw up (vomit) again and again it is possible that you are pregnant. Generally women tend to lose their control over bladder when pregnant; it is very hard to control excretion of urine. Morning sickness or nausea is a tendency that is observed in pregnant women. They cannot resist throwing up again and again during the second and third months of pregnancy. Enlargement or soreness in breast is also indicates that possibly you are pregnant. Breast starts to grow big and become painful. If your breast is releasing colostrums, uterus is enlarged or you are getting a lot of stretch marks there is a possibility that you may be pregnant. In case you have frequent strange cravings like you have never had in past may be a n indication that you are pregnant.

However, these are not confirmed signs of pregnancy. Some of these symptoms when experienced together increase the probability of one’s pregnancy. You should immediately rush for a pregnancy test if you are even a little doubtful. This will clarify your doubts as it is a reliable way to test your pregnancy by yourself. You can also trace the pregnancy by an ultrasound test but home pregnancy strip test is more handy, cheap and reliable.

In case you are planning to conceive these are some symptoms that might be pointing towards your positive result on a pregnancy strip. Be happy you are experiencing such phenomenon and consult a doctor as soon as possible. Apart from all this reflect on your inner sight you can feel it when you are pregnant and the tests suggested above are just a primary confirmation.

In case you do not want to bear there are ways to get out of the web. Contraceptive pills are available in the market which can be a help in forbidding any pregnancy. There are pills that you can take within 72 hours after having unprotected sex to prevent pregnancy but its intake again and again can cause side effects. If you detect a positive on the pregnancy strip, you will have to abort it whether it is by an abortion pill or by any other method.

About The Author: Camila is a writer/blogger. She loves writing, traveling and reading books. She contributes on Josh Fink

Source:
http://www.biotechblog.org/entry/good-home-pregnancy-tests/

What is potassium cyanide??

A chemical compound with the chemical formula KCN is commonly known as the Potassium cyanide. This is a colorless crystalline compound, highly soluble in water and is similar in appearance as that of sugar. Potassium cyanide is considered to be highly toxic in nature. Potassium cyanide is considered to be one of the most deadly compounds being discovered till date.

Production of Potassium Cyanide:

Potassium Cyanide can be produced mainly by treating hydrogen cyanide in the presence of a fifty percent of an aqueous solution of potassium hydroxide. After that the aqueous solution is either evaporated in a vacuum or by treating the form amide in the presence of potassium hydroxide. On an average per year approximately fifty thousand tons of potassium cyanide are being produced all over the world.

Use of Potassium Cyanide:

Potassium Cyanide is mainly used for the purpose of electroplating, organic synthesis of a number of chemical compounds, gold mining and so on. In accordance with the large scale use of Potassium Cyanide, it is also used in smaller scale applications like in the jewelry manufacturing industry for chemical buffing and gliding. Other than those mentioned earlier, Potassium Cyanide is also used by the entomologists as it is an excellent killing agent, and it has the unique capability of causing minimum damage to the highly fragile specimens.

Mystery about Potassium Cyanide:

Since, the time of its invention, the biggest mystery that has been surrounded with Potassium Cyanide, is about the taste of it. Due to the fact that Potassium Cyanide is exceedingly poisonous substance and can cause death of a person in seconds, the taste of it has remained a mystery or a fact yet to be known to the world. Though, many researches and tests have been conducted to find the taste of Potassium Cyanide but none of them could come up with the appropriate result.

Different views about the taste of Potassium Cyanide:

There has been number of views among the scientists about the taste of the Potassium Cyanide, some of them are as follows:

· Since on hydrolysis of KCN, the resultant compound that are formed are KOH and HCN, which are strong base and weak base respectively, Potassium Cyanide is confirmed to be basic nature. Since at room temperature HCN is a gas which evolves and the solution is expected to have more KOH, so the taste of Potassium Cyanide is assumed to be bitter.

· Some, scientists who have died while finding the taste of Potassium cyanide, could only write the alphabet “S” before dying, so it is not conclusive whether it is sour, sweet or salty in taste.

Conclusion:

Though, a huge number of scientists sacrificed their lives in order to find the taste of Potassium cyanide, but it remained a mystery for long, until and unless a goldsmith from India named MP Prasad in an attempt to commit suicide with the help of Potassium cyanide could finally reveal the taste of Potassium cyanide. As per the suicide note of him the taste of Potassium Cyanide is very much acrid, that is irritatingly harsh and sharp. This fact about the taste of Potassium cyanide is approved by the World Health Organization and is marked as an extraordinary discovery in the field of science.

Source:
http://www.biotechblog.org/entry/mystery-cyanide-taste/

DNA, deoxyribonucleic acid it is the backbone of all living creatures on earth. It is a molecule, which is having a double helical structure and encoded with genetic instructions. It leads to the functioning of all living beings including viruses. DNA profiling is done by the forensic scientists. It depicts the nature of the DNA and act as a person identifier. By knowing the genomic sequences a scientist could easily predict the DNA of the person.

Identification Of Diseases

In this era this technology has become a boon or us in many ways. This concept of DNA testing is booming in the market like anything. It has become the latest rage specially in the health care market. Many companies are there who will promote you the test kits and let you know about the diseases like cardiac problem, any alzimers syndromes, any indication of breast cancer if have any. But here comes the argument many feeble minded people are there who will completely go against it. As the procedures includes blood testing and many people are phobic of syringes, then comes the acceptance of the disease if have any.

Benefits of DNA testing

Many women in our country are facing problem with breast cancer. As they are afraid of testing their blood and DNA. They don’t have the exact DNA marker. This is a big concern for the physicians as well. It is always recommended having a DNA testing for a healthy life. The risk factors get decreased than before and longevity will increase. Myopic thinking should be removed from the society and should learn to accept the truth. DNA testing will also give information about the allergic reaction with various pathogens. The life will be in a proper and better shape.

Detection of criminals

Normal people have a vague idea about this DNA testing which is not at all harmful. Through DNA testing crimes can also be detected. Like in the forensic lab the victim’s body will undergo a scrupulous check up and easily it will be detected about the death of the person. Many criminal lawyers take support from this process which make their job easy to detect the criminal. Though it’s not a good indication for the crime masters. By taking the blood sample or from the foot steps even, of the suspected person it will unveil the truth of the real murder. It can save our nation from crimes.

Detection of pregnancy

Many unrevealed and awful activities like rape case, illegal affairs lead to pregnancy. In many cases the male denied for becoming a father. The lady could easily raise her voice for justice, here

Comes the major role of DNA testing which will easily catch hold of the real father. Sometimes it is not safe for the pregnant woman to have DNA testing as it might cause harm to the fetus. The illegal activities in our society have inflated than before so DNA testing should play a vital role in the society of crimes.The lady will get justice and to deliver her baby.

As a whole it’s a win-win situation because some hospitals testing the DNA of the fetus take place, as an outcome they reveal the gender, which might lead to a death of a baby girl.This is an illegal activity. Some lawyers are also against this. But in this contemporary era one must believe in DNA testing to save our nation.

Source:
http://www.biotechblog.org/entry/dna-testing-good-bad-discuss/

Fountain of youth is referred to a spring. If a person drinks the water of it, he or she can easily restore the youth again in themselves. In his writing Herodotus has also mentioned about this concept. This has become a kind of legend and many a famous author like Homer or Shakespeare have also discussed about in the literature. Now the biggest question is that whether there is really any kind of such fountain on this earth or not.

How the search goes on:

The search of such a fountain goes generation after generation because men have always wanted more youth. With the progress of science men have made many an incredible thing successful. The use of stem cells and many other related inventions have made huge change in human life. Men and women are getting longer and fitter life. More researches on cells are going on and scientists are working very hard to invent various things by the help of which we can keep our youth for longer time.

What the concept is:

Though the whole thing comes from a myth but the main aspect of this thought is to get back the life again. Man has always searched for immortality. According to scientists, now they have found out a way to continue your youth for longer time. Actually our body can have the charm of youth because of cell division. Normally a cell can divide for fifty times and then gradually it stops and the characteristics of old age begin to come in the body. Now the scientists have succeeded to produce such a cell which can divide it over 90 times and still it will not get slow down. Scientists have used an enzyme with the chromosomes the name of which is Telomerase. Telomere shortening is the actual reason of gradually getting old. Now this enzyme will stop the normal shortening process of telomere and thus it can help you to keep your youth in yourself for longer time.

Its drawback:

This enzyme is undoubtedly one of the most incredible inventions at the moment but it may have some drawbacks. According to some of the scientists this shortening process of telomere is a natural process. Now this natural process can eventually ward off cancer. Now by adding this enzyme this natural process of body defense will be destroyed. Some of the scientists are worried of the consequences of that. More experiments are going on and after the successful completion of them the scientists will be able to state the result of this new invention.

Searching for longer life:

Most of the people on this earth like to have a longer life especially a longer youth in which he will have ample energy to enjoy all the entertaining aspects of life. The concept of fountain of youth has been traditionally carried forward generation after generation because of this continuous wish of longer life of human being.

The myth of finding a fountain where the water can be found which can bring back youth may not be found physically. However, progress of science can assure a longer youth for human. In recent future man is going to live a longer enjoyable life.

About The Author: Claudia is a writer/ blogger. She loves writing, travelling and reading books. She contributes to Caribbean Cruise Line Scam 

Source:
http://www.biotechblog.org/entry/real-fountain-youth/

While the broader stock market fell Monday, many biotech shares continued to outperform.

The big mover was TG Therapeutics Inc. TGTX, -8.72% which soared 90% after releasing positive results from its Phase 3 clinical trial of its treatment for high-risk leukemia patients. The stock closed up $4.85 to $10.20 on 33.7 million shares, which is 34 times its daily average. The stock blew through several layers of resistance, but pulled back at the close below resistance from the April high at around $10.50. A breakthrough there should get the stock to $13 and then $15. Support is at the days low of $9.10 and then $8. Short interest of 22 times its average volume could accelerate the advance.

Concert Pharmaceuticals Inc. CNCE, +5.67% rocketed 62% Monday on news that Vertex Pharmaceuticals Inc. VRTX, +1.06% will be acquiring the companys cystic fibrosis drug, CTP-656. The stock closed at $15.64, up $5.99, at around the mid-range of the days action, which bodes well for a follow-through. Volume of 10.5 million shares was more than 85 times its average. Watch for a retest the days intraday high at $18.48, a breakthrough that could get the stock moving to test its highs from November 2015 at just under $25.

Kite Pharma Inc. KITE, +1.57% which we highlighted in our biotech article on Friday, followed through on Monday, up $1.37 to $73.90. FBR Capital mentioned the company in a research note in which it said that potential tax reform and FDA policy changes under President Trump could fuel acquisitions of clinical-stage biotech companies. RBC Capital Markets boosted its price target from $85 to $95. KITE surged last week after the company released a favorable earnings report and positive clinical data on its lead product candidate for treating patients with rare forms of blood cancer. Pulling back slightly on Thursday and Friday, the stock is now in a high-level mini-wedge formation, a break of which could lead to the next target at $90.

Amicus Therapeutics Inc. FOLD, +3.21% was relatively flat on Monday, down just 10 cents to $7.69, but is looking strong. As we noted in our article Friday, the stock rocketed 17% on Wednesday after the company CEOs daughter, Megan Crowley, who has Pompe disease, was highlighted during President Trumps address to Congress Tuesday night. The stock has broken out of a mini-consolidation pattern and across lateral resistance from its December high. At its intraday highs last week, the stock nearly reached the level it was at before its big gap down in December. If it can fill that gap, watch for a move next to $9.50.

Among other biotechs to watch, Supernus Pharmaceuticals Inc. SUPN, +5.40% reached a new all-time at $30.37 on Monday, before closing at $29.75, still up $1 in a down market. The drugmaker has been rallying in the past week since topping analysts forecasts in its fourth-quarter report last Wednesday. Watch for $32-$33 in the short term.

Foundation Medicine Inc. FMI, +2.05% gained $3, or 10.6%, to $31.30 on no news Monday. Stock in the diagnostic cancer analyses company has been up six days in a row since closing at $23.10 on Feb. 24. The rally has broken the stock out of a falling wedge pattern. Our initial target of $29 was exceeded Monday, and next target is near $35.

See Harrys video-chart analysis on these stocks.

The writer has no holdings in any securities mentioned.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

Read the original here:
Opinion: Harry Boxer's six biotechnology stocks to watch - MarketWatch

Track 1:Pharmaceutical Biotechnology

Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs.Pharmaceutical Biotechnologyis an increasingly important area of science and technology. It contributes in design and delivery of new therapeutic drugs,diagnosticagents for medical tests, and in gene therapy for correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes inhealthcarepractices and a significant contribution to the development of national economy.Biopharmaceuticalsconsists of large biological molecules which areproteins. They target the underlying mechanisms and pathways of a disease or ailment; it is a relatively young industry. They can deal with targets in humans that are not accessible with traditional medicines.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; Global Biotechnology Congress 2016, May 11th - 14th 2016, Boston, MA, USA;BiomarkerSummit 2016, March 21-23, 2016 San Diego, CA, USA; 14th Vaccines Research & Development, July 7-8, 2016 Boston, USA; Pharmaceutical &Biotech Patent LitigationForum, Mar 14 - 15, 2016, Amsterdam, Netherlands;

Track 2:Biotechnology in Health Care

Biotechnology in health care represents the complex of modern biological approaches in the field of healthcare research and industry. Healthcare Biotechnology methods are used primarily in pharmaceutical industry and modern clinical diagnostics. The research training in this domain is programmed for the candidates intending to develop their careers in scientific-research institutions, clinical anddiagnostic laboratories, analytical services,pharmacologicalandpharmaceutical companies, etc. For the first time in the history of human healthcare, biotechnology is enabling the development and manufacturing of therapies for a number of rare diseases with a genetic origin. Although individually rare, collectively thesediseasesaffect some 20-30 million individuals and their families with 70-80% having a genetic component requiring biotechnology as part of the solution.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; 3rd CaribbeanBiomedicalResearch Days, January 16-18, 2016, Rodney Bay, Saint Lucia; GlobalBiotechnologyCongress 2016, May 11th-14th 2016, Boston, MA, USA;BiomarkerSummit 2016, March 21-23, 2016 San Diego, CA, USA; 14thVaccinesResearch & Development, July 7-8, Boston, USA;Pharmaceutical&BiotechPatentLitigation Forum, Mar 14 - 15, 2016, Amsterdam, Netherlands; 4thBiomarkersinDiagnostics, Oct 07-08, 2015 Berlin, Germany, DEU.

Track 3:Food Biotechnology

Food biotechnology is a process scientists use to enhance the production,nutritional value, safety, and taste of foods. It can also benefit the environment by improving crops so that they need fewerpesticides. The concept is not new: For centuries farmers have selectively bred plants to pass on desirable qualities. For example, our ancestors began by replanting only corn seeds from the highest yielding and best tasting corn they grew each year. This process selected desirable genes and fixed them by growing the seeds of the selected crop year after year. The result: the golden, deliciously sweet product we now enjoy. Modernfood biotechnologyis a refined version of this same process. Today, scientists obtain desired traits by adding or removing plant genes. This process is called genetic engineering or recombinant DNA technology. It yields foods that are flavorful, contain more vitamins and minerals, and absorb less fat when cooked, and gives us crops that are more resistant to pests and insects. Food biotechnology holds great promise for the future. Soon, fruits and vegetables may be made to resist drought. We may remove allergens from foods such as nuts. Scientists may develop plants that absorb nitrogen more efficiently and need lessfertilizer. The benefits are nearly limitless!

RelatedBiotechnology Conferences

3rdGlobal Food Safety Conference, September 01-03, 2016, Atlanta USA; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;BiologicallyActive Compounds inFood, October 15-16 2015 Lodz, Poland; World Conference on InnovativeAnimal NutritionandFeeding, October 15-17, 2015 Budapest, Hungary; 18th International Conference onFood ScienceandBiotechnology, November 28 - 29, 2016, Istanbul, Turkey; 18th International Conference onAgricultural Science,Biotechnology,FoodandAnimal Science, January 7 - 8, 2016, Singapore; International IndonesiaSeafood and Meat, 1517 October 2016, Jakarta, Indonesia; International Conference of Eco-friendlyApplied BiologicalControl ofAgricultural PestsandPhytopathogens, 19 -22 October 2015, Cairo, Egypt;Food Structures,DigestionandHealth3rd International Conference, 28-30 October, Wellington, New Zealand; Conference ofCereal BiotechnologyandBreeding, November 2-4, 2015, Berlin, Germany; AdvancedWater TreatmentforFood & Beverage, November 3-4, 2015 Amsterdam, Netherlands.

Track 4:Industrial and Microbial Biotechnology

Industrial or white biotechnology uses enzymes and micro-organisms to make biobased products in sectors such as chemicals,food and feed, detergents, paper and pulp, textiles andbioenergy. The application of industrial biotechnology has been proven to make significant contributions towards mitigating the impacts of climate change in these and other sectors. In addition to environmental benefits, biotechnology can improve industrys performance and product value and, as the technology develops and matures,white biotechnologywill yield more and more viable solutions for our environment. These innovative solutions bring added benefits for both our climate and our economy.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; BIO IPCC Conference, Cary, North Carolina, USA; World Congress onIndustrial Biotechnology, April 17-20, 2016, San Diego, CA; The European Forum forIndustrial Biotechnologyand theBioeconomy, 27-29 October 2015, Brussels, Belgium; 4thBiotechnologyWorld Congress, February 15th-18th, 2016, Dubai, United Arab Emirates; International Conference on Advances inBioprocess EngineeringandTechnology, 20th to 22nd January 2016,Kolkata, India; GlobalBiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA

Track 5:Nanobiotechnology

Nanobiotechnologyis beginning to allow scientists, engineers, and physicians to work at the cellular and molecular levels to produce major benefits to life sciences and healthcare. In the next century, the emerging field of nanotechnology will lead to new biotechnology based industries and novel approaches in medicine. Nanobiotechnology is that branch of nanotechnology that deals with biological and biochemical applications or uses. Nanobiotechnology often studies existing elements of living organisms and nature to fabricate newnano-devices. Generally, nanobiotechnology refers to the use of nanotechnology to further the goals of biotechnology. Some of the innovative challenges in the field of biology are: New molecular imaging techniques, Quantitative analytical tools, Physical model of the cell as a machine, Better ex-vivo tests and improvement in current laboratory techniques and Better drug delivery systems.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;NanoBioTech-Montreux, November 16-18, 2015, Switzerland; International Conference onNanobiotechnology(ICNB'16), April 1-2, 2016, Prague, Czech Republic; InternationalNanotechnologyConference & Expo, April 4-6, 2016 Baltimore, USA;

Track 6:Plant Biotechnology

Plant biotechnology is the technique used to manipulate the plants for specific needs or requirement. In traditional process seed is the major source for germinating a new plant but the advance method is independent that combines multiple needs to get the required traits.Plant biotechnologymeets the challenge that includesgenomics,genetic engineering,tissue culture, andtransgenic cropsetc. These biotechnological applications allow researchers to detect and map genes and discover their functions, selection of specific genes in genetic resources and its breeding and to customize the plant according to the requirement by transferring the genes of specific traits to combine with others to create a new species. The recent advances in plant biotechnology provide potential way to make improvements much more quickly than conventionalplant breedingtechniques. Plant tissue culture is a part of plant biotechnology which is the collection of many techniques that is used to maintain and grow plant, plant cells, plant tissues under controlled sterile conditions over the nutrient medium. Plant tissue culture is the convenient method produce clones of a plant through the process calledmicropropagation. The main advantage of this method is to produce exact and multiple copies of plants with good desired properties like good flowers, fruits and other characters within small span of time. Production of multiple plants without seed, production of genetically modified plants, the tissue culture plants are resistant to the diseases,pathogensand pests, also it is the best method to store the gene pools and many more

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; 3rd CaribbeanBiomedicalResearch Days, January 16-18, 2016, Rodney Bay, Saint Lucia;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; 18th International Conference onAgricultural Biotechnology, Biological and Biosystems Engineering, January 18-19, 2016, London, United Kingdom; 2nd International Conference on Biotechnology andAgriculture EngineeringApril 08-09 2016 in Tokyo, Japan; Food Structures, Digestion andHealth3rd International Conference, 28-30 October 2015, Wellington, New Zealand; 3rd Conference ofCereal Biotechnologyand Breeding, November 2-4, 2015, Berlin, Germany;

Track 7:Agricultural Biotechnology

Agricultural biotechnologyis the area of biotechnology involving applications to agriculture. Agricultural biotechnology has been practiced for a long time, as people have sought to improve agriculturally important organisms by selection and breeding. An example of traditional agricultural biotechnology is the development of disease-resistant wheat varieties by cross-breeding different wheat types until the desired disease resistance was present in a resulting new variety. Modern agricultural biotechnology improves crops in more targeted ways. The best known technique is genetic modification, but the term agricultural biotechnology (or green biotechnology) also covers such techniques as Marker Assisted Breeding, which increases the effectiveness of conventional breeding. Whatever the particular technology used, the crops may be destined for use for food,biomaterialsor energy production.Genetic modificationmeans that existing genes are modified or new genes included to give plant varieties desirable characteristics, such as resistance to certain pests or herbicides, or forvitaminfortification. Because only a few genes with known traits are transferred, GM methods are more targeted and faster thantraditional breeding. Biotechnology has helped to increase crop productivity by introducing such qualities as disease resistance and increased drought tolerance to the crops.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrialBiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; Conference onAgricultural Statistics2015, Sarawak, Malaysia; 2nd International Conference onGlobal Food Security, 11-14 October 2015, Ithaca, United States; 5th International Conference onOrganic AgricultureSciences, 14th-17th October 2015, Bratislava, Slovakia; 18thInternational Conference onAgricultural, Biotechnology, Biological and Biosystems Engineering, January 18-19, 2016, London, United Kingdom; 2nd International Conference on Biotechnology andAgriculture EngineeringApril 08-09 2016 in Tokyo, Japan;Food Structures, Digestion andHealth3rd International Conference, 28-30 October 2015, Wellington, New Zealand; 3rd Conference of Cereal Biotechnology andBreeding, November 2-4, 2015, Berlin, Germany; AdvancedWater TreatmentforFood & Beverage, 3-4 Nov 2015, Amsterdam, Netherlands

Track 8:Environmental Biotechnology

Environmental biotechnology is biotechnology that is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. The International Society for Environmental Biotechnology defines environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments (land, air, water), and for environment-friendly processes (green manufacturing technologies and sustainable development)

RelatedBiotechnology Conferences

5th International Conference onBiodiversity, March 10-12, 2016 at Madrid, Spain; International Conference on Biotechnology andEnvironmental ManagementSeptember 14-15 Milan, Italy; 6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA; International Conference onGreen Energy& Expo September 21-23, 2015 Orlando, FL, USA; International Conference on Environment,Energy and Biotechnology, May 25, 2016 Jeju Island, Republic of Korea; International Conference on Energy andEnvironmental Biotechnology, November 24 - 25, 2015 Dubai, UAE; Science for theEnvironmentConference 2015, October 1-2 2016 Aarhus, Denmark; International Conference onEnvironmental Scienceand Technology 14th to 17th May 2016, Antalya, Turkey

Track 9:Marine Biotechnology

Marine Biotechnology is a relatively new field of study, having emerged in the past few years. The Marine Biotechnology is intended to host scientific contributions inmarine sciencethat are based on the enormousbiodiversityof marine ecosystems and the genetic uniqueness of marine organisms to develop useful products and applications.Aquaculture& Marine Biotechnology have been the subject of great importance not only because of the sustainable utilization of their resources to feed the billion people of the world but also for the future challenges for discovery of new products and process development of economic importance through its treasure recognition and diversification. Apart from contributing to high quality and healthy food (aquaculture),nutraceuticalsand medicinal products (anti-cancer andantimicrobials), this sector is expected to contribute to sustainable alternative source of energy (biofuelfrom microalgae) and environmental health. Marine Biotechnology is capable of making an important contribution towards meeting impending challenges like a sustainable supply of food and energy and human health.

RelatedBiotechnology Conferences

5th International Conference on Biodiversity, March 10-12, 2016 at Madrid, Spain; International Conference on Biotechnology and Environmental Management September 14-15, Milan, Italy; 6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;BioMarine2015, 12-14 Oct 2016, Wilmington, NC, United States; International Conference onMarine BiotechnologyandBioprocessing, December 10 - 11, 2015, Sydney, Australia; Annual world congress ofMarine Biotechnology-2015, November 6-8 2015, Qingdao, China;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; Annual InternationalMarine BiotechnologyConference, Nov 20, 2013, Brisbane, Australia

Track 10:Current Scenario of Biotechnology

Due to multidisciplinary nature of the field of biotechnology, a wide range of different branches of science have made significant contributions to the fast development of this field. Some of these disciplines are-biochemical engineering,physiology,biochemistry,food science,material science,bioinformatics,immunology,molecular biology,chemical engineeringetc. Biotechnology is also improving the lives of people around the world. Biotechnology also has affected economy in a positive way due to the creation and growth of small business, generation of new jobs. Agricultural biotechnology has reduced our dependency on pesticides.Bioremediation technologiesare being used to clean our environment by removing toxic substances from contaminated ground water and soils. about 60% of the biotechnology products in the market are healthcare products and 21% are products used in agriculture andanimal husbandry. A considerable amount of efforts in research are on, to use and extract benefit from this interesting and upcoming field for the betterment of human life and the environment. Many biochemical companies are involved in the production of biotechnological products usinggenetic engineeringtechniques.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;

Track 11:Animal Biotechnology

Biotechnology provides new tools for improvinghuman healthand animal health and welfare and increasinglivestock productivity. Biotechnology improves the food we eat-meat, milk and eggs. Biotechnology can improve an animals impact on the environment. And biotechnology enhances ability to detect, treat and prevent diseases. Just like other assistedreproduction techniquessuch asartificial insemination,embryo transferandin vitro fertilization, livestockcloningimproves animal breeding programs allowing farmers and ranchers to produce healthier offspring, and therefore producer healthier, safer and higher quality foods more consistently.

RelatedBiotechnology Conferences|Biotechnology Events|Biochemistry Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BiomarkerSummit 2016, March 21-23, 2016 San Diego, CA, USA; 14thVaccinesResearch & Development, July 7-8, Boston, USA;

Track 12:Biomass and Bioenergy

Bioenergyis the chemical energy contained in organic matter (biomass) which can be converted into energy forms that we can use directly, such as electricity, heat and liquid fuel. Biomass is any organic matter of recently living plant or animal origin. Unlike coal, the organic matter is notfossilised.Bioenergy plantscan range from small domestic heating systems to multi-megawatt industrial plants requiring hundreds of thousands of tonnes ofbiomassfuel each year. A variety of technologies exists to release and use the energy contained in biomass. They range from combustion technologies that are well proven and widely used around the world for generating electricity generation, to emerging technologies that convert biomass intoliquid fuelsfor road, sea and air transport.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; IEABioenergyConference 2016, October 26th-29th2016, Berlin, Germany; Summit onIndustrial biotechnologyandBioenergy, December 7 -9, 2016 San Diego, California; Energy Conference, Des Moines, Oct 13-15 Iowa, USA; EuropeanBiomassConference and Exhibition Amsterdam, 6-9, June, Germany Netherlands; EcoSummit 2016, August 29 - September 01 2016, Montpellier, France; InternationalBioenergyand Bioproducts Conference, October 28-30, 2016 Atlanta, Georgia; 2016 InternationalBiomassConference & Expo, Charlotte, North Carolina;World Bioenergy2016, May 24-26 2016, Stockholm, Sweden; 2016 InternationalFuel EthanolWorkshop & Expo, June 20-23, 2016 Milwaukee, Wisconsin.

Track 13:Biotechnology and its Applications

The applications of biotechnology are so broad, and the advantages so compelling, that virtually every industry is using this technology. Developments are underway in areas as diverse aspharmaceuticals, diagnostics,textiles,aquaculture,forestry, chemicals, household products,environmental cleanup,food processingand forensics to name a few. Biotechnology is enabling these industries to make new or better products, often with greater speed, efficiency and flexibility. Biotechnology holds significant promise to the future but certain amount of risk is associated with any area.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA; IEABioenergyConference 2016, October 26th-29th2016, Berlin, Germany; Summit onIndustrial biotechnologyandBioenergy, December 7 -9, 2016 San Diego, California;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;

Track 14:Biotechnology Market

The growth of Biotechnology industry as per Transparency Market Research is estimated to observe substantial growth during 2010 and 2017 as investments from around the world are anticipated to rise, especially from emerging economical regions of the world. The report states that the global market for biotechnology, studied according to its application areas, shall grow at an average annual growth rate of CAGR 11.6% from 2012 to 2017 and reach a value worth USD 414.5 billion by the end of 2017. This market was valued approximately USD 216.5 billion in 2011. The market of bioagriculture, combined with that of bioseeds, is projected to reach a value worthUSD 27.46 billionby 2018. The field of biopharmaceuticals dominated the global biotechnology market and accounted for 60% shares of it in the year 2011. Many biotechnological industries flourished by the technological advancements leading to new discoveries and rising demands from the pharmaceutical and agricultural sectors.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 15: Biotech Companies and Market Analysis

The biotechnology community in Europe has seen significant growth in recent years. By establishing itself in several key niche markets, the European biotech and pharma industries have thrived in the global biopharmaceutical market. Europe high standards for their life science educational systems have increased the level of growth and the quality of Europes workforce and broadened Europes reach within the world. With a dedication to innovation and research, Europe has established itself as a leader in biotechnology.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 16: Biotech Startups and Funding:

Biotechnology being an emerging industry, game-changing strategies and relevant application of the knowledge-intelligence resource pool, drive the process of growth. Europe Biotechnology seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 17: Advances in Biotech Manufacturing

The biotechnology community in Asia has seen significant growth in recent years. By establishing itself in several key niche markets, the European biotech and pharma industries have thrived in the global biopharmaceutical market. Asias high standards for their life science educational systems have increased the level of growth and the quality of Asias workforce and broadened Asias reach within the world. With a dedication to innovation and research, Asia has established itself as a leader in biotechnology.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

Track 18: Biotech Investors and Grants

The biotechnology industry hauled in $2.3 billion worth of venture capital investments during the second quarter of this yeara 32% increase over the prior quarter, according to the newest MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), with data from Thomson Reuters. The 126 deals struck during the period marked the biggest quarterly investment in biotech since the MoneyTree report first came out in 1995, and it brought the total for the first half to $3.8 billion.

RelatedBiotechnology Conferences

6thWorld Congress onBiotechnology, October 05-07, 2016, New Delhi India; 10thAsia PacificBiotechCongress July 25-27, 2016, Bangkok, Thailand; 2ndIndustrial BiotechnologyCongress, July 28-29, 2016, Berlin, Germany; 12thBiotechnologyCongress, Nov 14-15, 2016, San Francisco, USA;Global BiotechnologyCongress 2016, May 11th - 14th 2016, Boston, MA, USA;BIO Investor Forum, October 20-21, 2015, San Francisco, USA; BIO Latin America Conference, October 14-16, 2015, Rio de Janeiro, Brazil; BioPharm Americ 2015-8thAnnual International Partnering Conference, September 15-17, 2015, Boston, MA, USA;

8th Euro Biotechnology Congress (Euro Biotechnology-2015) was held during August 18-20, 2015 at Flemings Conference Hotel, Frankfurt, Germany. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who made this conference fruitful and productive.

This conference was based on the theme Biotechnology for a Better Tomorrow which included the following scientific tracks:

Biotechnology in Health Care Environmental Biotechnology Industrial Aspects of Biotechnology Stem Cells and Regenerative Medicine Marine Biotechnology and Aquaculture Agriculture Biotechnology Animal Biotechnology Food and Bio Process Biotechnology Cell and Molecular Biology Nanobiotechnology Genetic Engineering and rDNA Technology Current Scenarios and other allied areas of Biotechnology

We are thankful to our below Honourable guests and Keynote Speakers for their generous support and suggestions.

Manfred T Reetz Philipps-University, Germany

W Tim Miller - Echelon-Frontier Scientific Inc, USA

Wilfried Schwab - Technische Universitt Mnchen, Germany

Aline Zimmer- Merck Millipore, Germany

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

Increasing the efficiency of directed evolution of enzymes: Manfred T Reetz, Philipps-University of Marburg, Germany

Trade secrets and laboratory security: Frontier Scientific Inc, USA

Aroma glucoside production: Wilfried Schwab, Technische Universitt Mnchen, Germany

Chemically modified cysteine in fed-batch processes and impact on CHO specific productivity: Aline Zimmer, Merck Millipore, USA

Synthetic mRNAs present a rapidly growing technology: Optimized tool for stem cell generation and for manipulating cellular phenotypes : Guido Krupp, Amptec GmbH, Germany

Novel synthetic anti-microbial defensins through confrontational selection and screening of yeast libraries: K Yankulov, University of Guelph, Canada

Long acting recombinant glycoprotein hormones: From bench to clinics, Fuad Fares, University of Haifa, Israel

Poster Session was judged by K Yankulov, University of Guelph, Canada

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Euro Biotechnology-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Biotechnology & Biomaterials as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the 11th Euro Biotechnology Congress" to be held during November 07-09, 2016 at Alicante, Spain

Let us meet Again @ Euro Biotechnology-2016

Biotechnology-2014

OMICS Group Conferencessuccessfully hosted its premier5thWorld Congress on Biotechnologyduring June25-27, 2014 Valencia Conference centre, Valencia Spain

This World congress was accomplished by the support of European Biotechnology Thematic Network Association (EBTNA), Valencia Bioregion (BIOVAL), Federation of Spanish Biotechnologist (FEBiotec) and Societ Italo-Latinoamericana di Etnomedicina (SILAE). Biotechnology-2014 marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This5thWorld Congress on Biotechnologywas based on the theme the theme Biotechnology: Meeting the Needs of a Changing World which has covered the below scientific sessions:

The conference was greeted by the welcome message ofProf. Cheorl-Ho KimSung Kyun Kwan University, Korea and moderated byProf. Martin J. DSouza, Mercer University, USA. The support was extended by the below honourable guest Em. Prof.Marc Van Montagu, (World Food Laureate 2013) University of Gent, Belgium, Prof.Roberto Gaxiola, Arizona State University, USA, Prof.Ara Kanekanian, Cardiff Metropolitan University, UK, Prof.Manuel P. Alonso,University of Valencia, Spain, Prof.Cheorl-H. Kim,Sung Kyun Kwan University,Dr. Srinubabu Gedela, OMICS Group Inc, USA and below keynote lectures:

OMICS GroupInternational acknowledge the support of below Chairs and Co-chairs foe whom we were able to run smoothly the scientific sessions includes: Alain Goossens, Ghent University, Belgium, Oscar Vicente, IBMCP, Polytechnic University of Valencia, Spain, Ara Kanekanian, Cardiff Metropolitan University, UK, Ana M. Hortigela, Instituto de Medicina Genmica, Spain, Cheorl-H Kim, Sung Kyun Kwan University, Korea, Martin J. DSouza, Mercer University, USA, Marina V. Frontasyeva, Joint Institute for Nuclear Research, Russian Federation, Zlatka Alexieva, Bulgarian Academy of Sciences, Bulgaria, Salvador Ventura, Universitat Autnoma de Barcelona, Spain, Giuseppe Manco, Institute of Protein Biochemistry, National Research Council (CNR), Italy, Aihua Liu, Qingdao Institute of Bioenergy & Bioprocess, CAS, China, Amparo Pascual-Ahuir Giner, Universidad Politecnica de Valencia, Spain.

The rest is here:
Biotechnology Conferences | Biotechnology Events | CPD ...

Introduction

Genetic disorders are becoming common nowadays due to stressful modern lifestyle. Latest technologies are the added values to create many genetic disorders. To overcome the disorders, Gene therapy is a blessing. In order to compensate abnormal genes and make a good gene, genetic material is introduced into cells. In this way, mutated gene will act as a normal gene. Let us see in detail.

Ways to insert the gene

There are indirect ways need to be followed to make a gene to function as if it is inserted directly does not function. Carrier also called as vector is used to deliver the gene. In the place of vectors, virus play the role as they are getting modified and hence people are not affected with new diseases when it is integrated into the chromosome of the human cell.

The vectors need to get injected to specific tissue in the body or outwardly patient’s cell is removed and exposed to the vector. In either of the ways need to be again returned to the patient. Successful treatment makes proper genes and genetic disorders get solved.

Gene therapy for treating cancer

Cancer is the dangerous disease and there are many ways to cure cancer including surgery, chemotherapy, and radiation. But cancerous cells in due course again spread and hence it is a deadly disease. Gene therapy is the best way discovered nowadays for treating cancer.
Let us see the basic fundamentals of cells. cells include packets of data in genes, created either from DNA or RNA. Sequence is there for DNA and if it is in the order, there will be no problem. But at the same time If there is disorder occurs in portion of the genes either turning or changing the position, cells lost their control and abnormal growth is seen which result in cancerous tumors. It can spread in mouth, breast, lung etc.,

Specialists in Gene therapy analyze the patient’s criticality first and follow the treatment procedures. One way is they replace missing or mutated genes into wholesome genes. Inserting totally new genes for fighting cancer, placing DNA into cancerous cells to undergo chemotherapy and radiation or injecting bad gene to destroy them etc., Mesothelioma type of cancers are not at all responded in formal therapies and hence one need to undergo gene therapy essentially. Need to have consultations with doctors to overcome their deadly disease.

Gene therapy importance

Doctors decide whether gene therapy is suitable by the following approaches. If genetic disorders are from mutations in one or more genes or whether a normal copy of the gene that is available in the patient is enough to fix the problems in the affected cells, then doctors determine that gene therapy will be more helpful rather than going for traditional methods.

Conclusion

Genetic engineering is a vast topic. Latest Science innovations in the field of genetic engineering yields for gene therapy. Doctors and scientists together working to find out whether gene therapy is the best suitable way for treating deadly diseases like cancer and others. Let us salute for the positive force of gene therapy.

Source:
http://www.biotechblog.org/entry/biotechnology-gene-therapy/

<-- Manitboa Biotech Company Name

City

Annapolis

Annapolis

Annapolis

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Bethesda

Bethesda

Bethesda

Clarksville

Cockeysville

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Elkridge

Frederick

Frederick

Fredrick

Frederick

Frederick

Frederick

Frederick

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Galena

Germantown

Germantown

Germantown

Germantown

Germantown

Glen Burnie

Hanover

Havre de Grace

Hunt Valley

Lexington Park

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Savage

Silver Spring

Sparks

Sparks

Visit link:
Biotech, Pharmaceutical, Medical Device, and Chemical ...

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces theBIO International Convention, the worlds largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.BIOtechNOWis BIO's blog chronicling innovations transforming our world and the BIO Newsletter is the organizations bi-weekly email newsletter.Subscribe to the BIO Newsletter.

Corporate members range from entrepreneurial companies developing a first product to Fortune 500 multinationals. We also represent state and regional biotech associations, service providers to the industry, and academic centers. Our members help foster a healthy economy by creating good-paying, biotechnology jobs.

Not only do we advocate for our members, but we also work towards enriching the industry with networking, partnering and education opportunities. We organize the BIO International Convention, the global event for biotechnology, along with many other industry-leading investor and partnering events held around the world. In addition, we produce BIOtechNOW, an online portal and monthly newsletter chronicling innovations transforming our world.

BIO is organized into four different sections to best represent our members and their goals:

We serve the needs of small-to-medium size companies, most of whom do not yet have major products approved and on the market. Whether advocating for pro-innovation tax policies to encouraging an economic and policy environment to foster biotech investment, we focus on critical issues affecting smaller companies and build programs to enhance their development.

We promote biomedical innovation by developing and advocating for public policies that represent the best interests of members focused on human health. We break-down the barriers that impede American innovation by reducing bureaucratic hurdles to lifesaving technologies. Among the priority issues are matters affecting the healthcare-related regulatory and reimbursement climate, pandemic and biodefense preparedness, publicly funded scientific research, and personalized medicine.

We promote the use of industrial enzymes, conversion of biomass to energy and chemicals, and innovative clean up technologies. We work closely with the U.S. Congress, federal agencies, and international organizations to encourage the development of technologies that make our lives and environment cleaner, safer and healthier.

We create and advance industry policies on all food and agriculture biotechnology issues related to international affairs, government relations, science and regulatory affairs, and media and public affairs. We work for a safe and clean supply of healthy food for a growing global population.

See the original post:
About BIO | BIO

Agriscience Educator Position Available at NERSBA The Northeast Regional School of Biotechnology and Agriscience currently has an Agriscience Educator position available. Read More... NERSBA Highlighted in the North State Journal The North State Journal recently published an article about NERSBA. Two of NERSBA's June 2016 Graduates, Shanicia Young and Noah Wynn, were highlighted in the article. To read the article, go to: http://www.nsjonline.com/article/2016/06/grad-for-unique-nenchigh-school. NERSBA Holds June 2016 Commencement Ten scholars graduated from NERSBA on Saturday, June 18th. ALL Graduates were recognized as NC Scholars, Honor Graduates and National Honor Society Members. These graduates have worked diligently to attain a high school diploma and an Associate's Degree in four years. Read More... NHS Holds a Blood Drive On Friday, April 8th, 2016, NERSBA National Honor Society hosted its first community service project; a Red Cross Blood Drive. The National Honor Society, headed by Mrs. Christi Rogerson and Mrs. Connie Smith, held the blood drive at the Northeast Regional School of Biotechnology and Agriscience Jamesville Location. A total of 45 people registered to donate at the blood drive. A total of 38 pints of blood were collected at the drive, 30 of Read More... NERSBA June 2016 Graduates Recognized The NERSBA 2016 Graduates were recognized at the Academic Awards Program on Thursday, May 26th. Even though NERSBA has a 5-year high school program, these scholars will graduate with their high school diploma and an Associate's Read More... 2016-17 FFA Officers Announced The newly elected officers for the 2016-17 school year were announced at the FFA Awards Program on Thursday, May 12th. The new officers are... Read More... English II Studies Julius Caesar Each of Mrs. Slade's English II classes was involved in a Socratic Seminar session about the Shakespearian play Julius Caesar on April 28. We discussed the events that happened in each Act during our reading and then we shared... Read More... Scholars Perform at Dance Recital Scholars who were enrolled in the Social Dance class at Martin Community College performed at their Spring Dance Recital on May 10th. They demonstrated 17 dances including the waltz, tango, continental, shag and electric slide they have learned from Ms. Wainwright, their instructor. They did an awesome job showing their dance skills! Junior-Senior Prom Held at Yankee Hall The NERSBA Junior-Senior Prom was held at Yankee Hall in Pactolus. Scholars had a wonderful evening dancing and socializing with other scholars The Prom King and Queen were Caleb Smith and Jade Henny. The Prom Prince and Princess were Maurice Perry and Rosie Lilley. Please check the Gallery for additional pictures of the prom. NERSBA Scholars Commit to Prom PROMise Several scholars who are attending the Junior-Senior Prom on May 6th made the commitment to Prom PROMise. Prom PROMise is when students make a commitment to have a safe and sober prom night. Read More... Scholar's Blog is Published by the American Forest Foundation Jordyn Gray, a 10th grade scholar at NERSBA, recently had her blog, "An Agricultural Perspective," published by the American Forest Foundation of Washington, D.C. at https://www.forestfoundation.org/an-agricultural-perspective. Read More... Scholars Tour the USCG Station All 9th grade scholars recently had the opportunity to tour the US Coast Guard Station in Elizabeth City. In the morning, scholars were given the opportunity to tour the C130 Aircraft which is used for surveillance and rescue missions and the HH-60T Medium Range Recovery Helicopter. Read More... Scholars Participate in MCC Career Day On April 3rd, the NERSBA sophomores and juniors participated in the Martin Community College Career Day. There were several workshops provided including Medical Assisting, Criminal Justice, EMT, Agriculture, and many more. The workshops provided... Read More... Scholars Participate in Engineering Design Activities During the March Satellite Day, scholars participated in engineering design activities. Scholars were given a roll of duck tape along with 3 popsicle sticks and were challenged with creating a device that would float and carry additional weight. Scholars used the Engineering Design Process to develop a product that would meet the requirements. Read More... Scholars Place at Tidewater Federation Events Several Scholars participated in the Tidewater Federation Events at the Vernon James Center in Plymouth on Thursday, April 7th. We had students compete in several events. Read More... Scholar Grows Lavender Plants for SAE All NERSBA scholars are required to complete a Supervised Agricultural Experience (SAE) project each year during their time at NERSBA. Scholars must document the time spent on this project, collect pictures relating to their experience and explain what was learned through this experience. Thomas Wilson, a junior at NERSBA,... Read More... NERSBA's Got Talent Show Held On March 22nd, some of our scholars participated in the NERSBAs Got Talent talent show. They spent weeks practicing their talents to get ready for the special night. The participants included... Read More... Robotics Club at NERSBA NERSBA has received a new addition to the school thanks to the improved club opportunities provided by the SMART lunch schedule. This new addition is the NERSBA Robotics Club, which highlights the Technology and Engineering part of STEM. Read More... NERSBA Scholars Place 2nd in Math Competition NERSBA scholars participated in the High School Mathematics Contest at East Carolina University on March 22, 2016. They placed second in the 1A school division. The scholars participated in Math 1, Math 2, Math 3, and Comprehensive competitions. Read More... Scholars Participate in FFA Week Throughout the week of February 22nd -27th NERSBA celebrated the National FFA week... Read More... NERSBA's Got Talent Show is Held NERSBA is full of people with many talents outside of the academic spectrum. With this in mind, the school hosted its first ever NERSBAs Got Talent Show on Thursday, December 10th. This talent show was the... Read More... NERSBA Holds NHS Induction Ceremony On Thursday, December 3, 2015, the Northeast Regional School of Biotechnology and Agriscience held its first ever National Honor Society Induction Ceremony. Fifty-two juniors and seniors were inducted into this organization based on their... Read More... Scholars Participate in Labs with NC BioNetwork Recently, NERSBA sophomore scholars in Ms. Gurganus chemistry classes participated in lab experiments with the NC BioNetwork. Read More... Scholars Participate in Moonlight Paddle Several NERSBA Scholars participated in the Inner Banks Outfitters'(IBXO) "Moonlight Paddle". Scholars, accompanied by guides & guests with Ms. Paul and Ms. VanderMeeden, entered the Pamlico River by Backwater Jacks and paddled towards the Washington draw bridge and turned back. Thank you to IBXO for this opportunity! (submitted by Noah Ayers) NERSBA Jacket Presentation Ceremony Recently Held On Thursday, October 22nd, the first FFA Jacket Ceremony at NERSBA was held. The ceremony was opened by our chapter president, Tyra Smallwood. Our principal, Mr. Davis, then continued the ceremony by talking about his experiences in the FFA back when he was in the same building we are in now. Margo Lilley, our Student Advisor, gave... Read More... Scholars Participate in Gem Mining Scholars in Ms. Paul's Earth and Environmental classes and Ms. Gurganus' Chemistry classes recently participated in a gem mining activity. Some juniors, seniors, teachers and their kids joined in the gem mining experience as well. In the Diamond Dels Gem Mining Adventure, scholars were given a box of rocks and minerals. They used... Read More... NERSBA Participates in NC State FFA Convention In June, over 20 NERSBA scholars attended the 87th North Carolina State FFA Convention held in Raleigh, NC. Teams that competed were: Parliamentary Procedure, Agriculture Tools & Materials (Tool ID), Horticulture, Floriculture, Agriscience Fair, and Creed. Eleven NERSBA scholars walked across the stage to receive their State FFA Degree. Senior Kaila Smith placed third in Agriscience Fair overall. We are proud of those students that attended! (submitted by Noah Ayers) NERSBA Scholars Participate in VIP for a VIP and Tour MCC On Tuesday, September 15, 2015, the junior and senior classes visited Riverside High School to participate in the VIP for a VIP program and visited Martin Community College for a tour and meet and greet with the professors. Read More... NERSBA Participates in Ag Expo 2015 On November 12, 2015, NERSBA scholars and staff participated in the Northeast Regional Ag Expo 2015 at the Senator Bob Martin Eastern Agricultural Center in Williamston, NC. The event provided attendees with the opportunity to meet with representatives of local, agriculture-related... Read More... NERSBA Holds 1st FFA Meeting for the 2015-16 School Year August 27th, 2015 was a very exciting day for the 2015-2016 NERSBA FFA officer team as well as the agriculture advisors. That day was our first chapter FFA meeting of the school year. All of the officers did a great job with their parts as well as the skit that was planned. Our goal as a chapter this year is to amplify FFA! (submitted by Summer Taylor) NERSBA Sharpshooters Participate in Tournament The North Carolina Wildlife Resource Commissions Hunter Education Program holds annual tournaments as an opportunity for youth to showcase outdoor skills and demonstrate safety. Teams are organized within public and private schools, while home-schooled students and teams representing organizations such as 4-H or FFA also can compete. On March 28th, NERSBA Read More... Scholars Tour the U.S. Coast Guard Station Ninth grade scholars recently toured the U.S. Coast Guard Station in Elizabeth City, N.C. They were able to learn... Read More... Scholars Participate in Field Experience at Oregon Inlet The field experience taken by NERBSA scholars to Oregon Inlet was to see what creatures live in different environments. Scholars went to two sites. The first site was... Read More... Scholars Transplant Potato Plants NERSBA scholars recently participated in potato transplanting with Mr. Mark Clough, a research at the Vernon G. James Research and Extension Center (VJC). Scholars learned about... Read More...

Go here to read the rest:
Northeast Regional School of Biotechnology and Agriscience

Latest News Sunday, Jun 5, 2016 Exelixis and its partner Ipsen announce phase 3 trial results of CABOMETYX (cabozantinib) tablets demonstrating significant overall survival benefit for previously treated patients with advanced renal cell carcinoma presented at ASCO Business Wire - 10 minutes ago J&J myeloma drug, in combo regimen, delays worsening of the disease Reuters - 15 minutes ago Exelixis Announces Genentech Presentation of Preliminary Phase 1B Trial Results for the Combination of Cobimetinib and Atezolizumab at ASCO 2016 Annual Meeting Business Wire - 15 minutes ago Stemline Therapeutics SL-401 Phase 2 BPDCN Data Delivered Via Oral Presentation at ASCO; High Response Rates Demonstrated Across All Lines As Enrollment Proceeds GlobeNewswire - Sat 7:07 pm ET TESARO Provides Pipeline Update at ASCO Investor Briefing GlobeNewswire - Sat 7:00 pm ET Data Presented at ASCO 2016 Builds upon Foundation of Abraxane Plus Gemcitabine as a First-Line Treatment in Patients with Metastatic Pancreatic Cancer Business Wire - Sat 5:32 pm ET Juno Therapeutics Investigational CAR T Cell Product Candidate JCAR015 Shows High Response Rates in Adults with B-cell ALL Business Wire - Sat 5:15 pm ET Saturday, Jun 4, 2016 Celldex Therapeutics CDX1401, CDX301 Combination Generates Potent NY-ESO-1 Immune Responses in Patients with Melanoma GlobeNewswire - Sat 2:02 pm ET Juno Therapeutics Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerability Business Wire - Sat 10:08 am ET Five Prime Therapeutics Announces Updated Data in Mesothelioma Patients from Ongoing Phase 1b Trial of FP-1039 Presented at 2016 ASCO Annual Meeting GlobeNewswire - Sat 9:24 am ET Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks PR Newswire - Sat 9:00 am ET Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial PR Newswire - Sat 9:00 am ET Aduro Biotech Presents Encouraging Anti-Tumor Response Data From Ongoing Phase 1b Study in Malignant Pleural Mesothelioma at ASCO GlobeNewswire - Sat 9:00 am ET Halozyme Presents Stage One Efficacy And Safety Analysis Of Phase 2 Clinical Study In Metastatic Pancreatic Cancer Patients Treated With PEGPH20 PR Newswire - Sat 9:00 am ET ARIAD Presents Data from Mutational Profiling in Crizotinib-Resistant Patients Treated with Investigational Medicine Brigatinib Showing Similar Response Rates in Patients with and without Secondary ALK Mutations Business Wire - Sat 7:35 am ET ARIAD Presents Long-Term Phase 1/2 Trial Follow up on Investigational Drug Brigatinib with Median Time on Treatment of 17 Months in ALK+ NSCLC Patients Business Wire - Sat 7:35 am ET INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation Business Wire - Fri 10:07 pm ET June is month to watch for more IPO news at bizjournals.com - Fri 8:47 pm ET [$$] Frazier, OrbiMed Join $100M Financing for Lion Biotechnologies at The Wall Street Journal Online - Fri 8:44 pm ET Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders PR Newswire - Fri 6:21 pm ET More Latest News...

Read more here:
Biotechnology Industry News: Industry Center - Yahoo Finance

Information for Enrolled Students Learn More

Biotechnology is the application of biological organisms, cells, or molecules to create products or services for the betterment of humans. The bachelor of science degree in biotechnology prepares students to tackle environmental, natural resource, agricultural and medical problems through training in molecular biology, cell biology, biochemistry, genetic engineering and related biological disciplines. As biotechnology is increasingly used to address such issues, it offers diverse career opportunities. The curriculum emphasizes the basic sciences with a strong foundation in biology, chemistry, calculus, and physics that prepares students for upper-level biology and chemistry courses, but encourages elective breadth in the social sciences, humanities, and environmental studies. The degree program provides sufficient breadth for a student to enter a clinical medical career, or other health profession. Students who complete this major will be qualified to enter the growing biotechnology-related job market or continue their studies in graduate or professional school.

The biotechnology major features a strong practical experience component. Each student is required to fulfill an internship, which could be in a local, national, or international company, medical unit, or government research laboratory. The objective of this internship is to give students experience working outside a purely academic setting. In addition, each student is required to perform one independent research project in a local, national, or international academic laboratory. The objective of the research requirement is to teach the student to develop and meet a research goal using the scientific method. During the senior year, each student is required to complete a senior project synthesis in which the results from either the internship or independent researchor bothwill be organized and presented as a seminar or poster.

In addition to ESF courses, below is a list of other courses offered at Syracuse University that can satisfy the directed electives requirement:

Link:
Biotechnology, Undergraduate Programs, SUNY-ESF